Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer

Florencia McAllister, MD, Maria F. Montiel, MD, Guneesh S. Uberoi, MD, Angad S. Uberoi, MD, Anirban Maitra, MBBS, and Manoop S. Bhutani, MD

  Abstract:  It is well known that pancreatic ductal adenocarcinoma has a high mortality rate. Despite progress in understanding the biology and genetic basis of this […]

The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis

Omar I. Massoud, MD, PhD, and Nizar N. Zein, MD

  Abstract: Thrombocytopenia is a well-known complication of liver cirrhosis. Although the pathogenesis of thrombocytopenia is not well understood, splenic congestion resulting from portal hypertension is […]

Updates to the Rome Criteria for Irritable Bowel Syndrome

Lin Chang, MD

  G&H  What are the Rome IV criteria, and how were they developed? LC  The Rome criteria were originally developed to understand functional gastrointestinal disorders (FGIDs), […]

Combination Therapy for Inflammatory Bowel Disease

Stephen B. Hanauer, MD

  G&H  What are the traditional treatment strategies for inflammatory bowel disease, and where does combination therapy fit among them? SH  The current algorithms for treating […]

HBV/HCV Coinfection and Possible Reactivation of HBV Following DAA Use

Robert G. Gish, MD

  G&H  How does coinfection affect hepatitis B and C virus? Are the diseases more severe or resistant? RG  When a person has active hepatitis B […]

Clostridium difficile Infection and the Role of Adaptive Immunity in the Microbiome

Monika Fischer, MD

  G&H  What is the pathogenesis of Clostridium difficile infection? MF  Clostridium difficile infection usually occurs in sus­ceptible patients after antibiotic therapy kills a good portion […]

An Overview of Endoscopic Ultrasound–Guided Gastroenteric Anastomosis

Mouen A. Khashab, MD

G&H  What are the indications for a gastroenteric anastomosis? MK  The main indication for a gastroenteric anastomosis is gastric outlet obstruction of either benign or malignant […]

Gastro-Hep News

Samantha Alleman

US Food and Drug Administration Approves Infliximab Biosimilar On April 21, 2017, the US Food and Drug Administration (FDA) approved infliximab-abda (Renflexis, Samsung Bioepis), an infliximab […]

Letter From the Editor: Pancreatic Cancer

Gary R. Lichtenstein, MD, AGAF, FACP, FACG

The poor prognosis of patients with pancreatic cancer is well recognized. According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results program, the 5-year overall […]

Back to Archive
Millennium Medical Publishing, Inc